Prevention and treatment of proteinuria in diabetic nephropathy

Phase 3

• Conditions: Glomerular disorder in diabetes mellitus; Diabetic nephropathy.; E10, E11,

• Registration Number: IRCT201104046123N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

willing to participate, no underlying malignancy, creatinin more than 1.8
Exclusion criteria: no any other diseases

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proteinuria. Timepoint: before intervention and two monthS after treatment. Method of measurement: Urine collection in 24 hrs.

Secondary Outcome Measures

Name	Time	Method
Hemoglobin A1C. Timepoint: Before intervention and two months after treatment. Method of measurement: taking blood sample.;Blood suger. Timepoint: Before intervention and two months after treatment. Method of measurement: take blood sample.